Gianpaolo Tibolla

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement.

PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement.

Journal: Atherosclerosis
Published: March 15, 2016

IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.

IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.

Journal: PloS one
Published: November 07, 2014

PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling.

PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling.

Journal: Nature communications
Published: October 10, 2014

HDL: to treat or not to treat?

HDL: to treat or not to treat?

Journal: Current atherosclerosis reports
Published: June 04, 2014

PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challenges.

PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challenges.

Journal: Vascular pharmacology
Published: May 30, 2014

Statins and skeletal muscles toxicity: from clinical trials to everyday practice.

Statins and skeletal muscles toxicity: from clinical trials to everyday practice.

Journal: Pharmacological research
Published: November 06, 2013

Targeting PCSK9 for hypercholesterolemia.

Targeting PCSK9 for hypercholesterolemia.

Journal: Annual review of pharmacology and toxicology
Published: October 29, 2013

Gene silencing approaches for the management of dyslipidaemia.

Gene silencing approaches for the management of dyslipidaemia.

Journal: Trends in pharmacological sciences
Published: October 30, 2012

Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.

Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.

Journal: PloS one
Published: May 18, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026